Apr 28, 2009
Adult stem cells may offer MS treatment
A preliminary study has shown that stem cells obtained from a patient's own fatty tissue may help improve symptoms in people living with MS.
Stromal vascular fraction (SVF) cells and other stem cells may be able to treat MS by limiting the immune reaction and promoting the growth of new myelin. Dr. Boris Minev, from the Division of Neurosurgery, University of California San Diego, said "None of the presently available MS treatments selectively inhibit the immune attack against the nervous system, nor do they stimulate regeneration of previously damaged tissue. We've shown that SVF cells may fill this therapeutic gap".
All three patients who were given this treatment have reported positive results such as increased balance, reduction in spasticity and improved cognition. The findings support further clinical evaluation of SVF cells in MS and other autoimmune conditions.
Click here to learn more.